Dr. Singh Discusses the Next Steps for Immunotherapy in GISTs – OncLive
OncLive |
Dr. Singh Discusses the Next Steps for Immunotherapy in GISTs
OncLive Arun S. Singh, MD, associate professor, UCLA David Geffen School of Medicine, discusses the next steps following a trial investigating single-agent and combination immunotherapy for patients with gastrointestinal stromal tumors (GIST). This phase II … |
